Rate of response to treatment in eyes with GA treated with Pegcetacoplan in a within-patient comparison using automated AI-based OCT biomarker quantifications in OAKS and DERBY (ARVO 2024 GA) - Apellis Medical Hub

Home / Congress Presentations / Geographic Atrophy / ARVO 2024

Rate of response to treatment in eyes with GA treated with Pegcetacoplan in a within-patient comparison using automated AI-based OCT biomarker quantifications in OAKS and DERBY

Share Via Email

The following information is available for educational purposes only. The information is not to be re-purposed or re-used in its current form or presentation for any personal or professional use. Apellis reserves the right to withdraw, modify or change the information that is available on this website at any time.